This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Palgrave Macmillan Announces Acquisition Of BioSocieties Journal From The London School Of Economics And Political Science

LONDON and NEW YORK, February 11, 2013 /PRNewswire/ --

Palgrave Macmillan is pleased to announce its acquisition of BioSocieties, an interdisciplinary journal for the social studies of life sciences, from the London School of Economics and Political Science.

The first journal of its kind, BioSocieties is committed to the scholarly exploration of the crucial social, ethical and policy implications of developments in the life sciences and biomedicine. BioSocieties is available via print or digital subscription, and also offers authors the option to publish their articles with immediate open access upon publication.

The quarterly journal, which has been published by Palgrave Macmillan for four years, will continue with the same editorial team led by Professor Nikolas Rose, Head of the Department of Social Science Health and Medicine at King's College London.

David Bull, Publishing Director of Journals and Reference at Palgrave Macmillan said: "We're delighted that we have added this young, exciting and international journal to the portfolio of journals we own.

"Life sciences and biomedicine is an exciting and vibrant area of research, and BioSocieties is at the cutting edge of its field, providing a crucial forum for leading scientists, social researchers, clinicians, regulators and other stakeholders."

Professor Paul Kelly, pro-director of teaching and learning at LSE, said: "Since its launch at LSE five years ago, BioSocieties has become the journal of choice not only for social scientists, but also for life scientists interested in the larger social, ethical and policy implications of their work. The School is delighted that the acquisition of BioSocieties by Palgrave Macmillan will ensure the journal continues to promote the findings of innovative research in this most exciting and challenging of fields of interdisciplinary endeavour."

Professor Nikolas Rose, Head of the Department of Social Science Health and Medicine at King's College London said: "I'm looking forward to continuing my working relationship with the team at Palgrave Macmillan. Together we will ensure BioSocieties carries on breaking out from the disciplinary boundaries within the social sciences and humanities, and develops new ways of thinking about the relations between biology and sociality and between the life sciences and society."

Notes to editors:

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,096.90 -106.47 -0.58%
S&P 500 2,098.53 -9.25 -0.44%
NASDAQ 4,967.1410 -12.76 -0.26%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs